Effect of 1, 25 dihydroxy vitamin D3 on cathelicidin expression in patients with and without cavitary tuberculosis.

Afsal, K.; Harishankar, M.; Banurekha, V.V.; Meenakshi, N.; Parthasarathy, R.T.; Selvaraj, P


Tuberculosis; 2014; 94; 599-605.


Summary: 1,25-dihydroxy vitamin D3 (1,25(OH)2 D3 ) is a potent immuno-modulator which induces LL-37, the active peptide of cathelicidin, and restricts the growth of Mycobacterium tuberculosis (Mtb) in human macrophages. In the present study, we investigated the effect of 1,25(OH) 2 D 3 on cathelicidin antimicrobial peptide (CAMP) expression in healthy controls (HCs) and pulmonary tuberculosis (PTB) patients. Peripheral blood mononuclear cells (PBMCs) from 50 HCs and 35 PTB patients were cultured for 72 h either with Mtb alone or Mtb with 1,25(OH)2 D3 at 10 7 M concentration. 1,25(OH)2 D3 significantly up regulated the macrophage phagocytosis, CD14, CAMP gene expression and hCAP18 protein in HCs and PTB patients ( p < 0.05). A significant positive correlation was observed between macrophage phagocytosis and CAMP gene expression in both the study groups ( p < 0.05). Moreover, 1,25(OH)2 D3 up regulated CAMP gene expression was more prominent in PTB patients without lung cavity (less severe form of disease) as compared to patients with cavitary TB (severe form of disease) ( p < 0.05). The present study suggests that vitamin D may be used as an adjunct to anti-TB treatment and may be useful for a quicker recovery from less severe forms of TB disease.


Keywords : Vitamin D; CD14; Cathelicidin; PTB; Lung cavitation


Back to List of publications / Home